Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Gail Matters, MS, PhD

Gail Matters, MS, PhD

Associate Professor, Department of Molecular and Precision Medicine
Associate Professor, Department of Medicine
Scientific Program:Next-Generation Therapies
GLM14@psu.edu

Recent Publications

2024

Abraham, T, Armold, M, McGovern, C, Harms, JF, Darok, MC, Gigliotti, C, Adair, B, Gray, JL, Kelly, DF, Adair, JH & Matters, GL 2024, 'CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery', Biomedicines, vol. 12, no. 5, 1024. https://doi.org/10.3390/biomedicines12051024
Castro, R, Adair, JH, Mastro, AM, Neuberger, T & Matters, GL 2024, 'VCAM-1-targeted nanoparticles to diagnose, monitor and treat atherosclerosis', Nanomedicine, vol. 19, no. 8, pp. 723-735. https://doi.org/10.2217/nnm-2023-0282

2021

Abraham, T, McGovern, CO, Linton, SS, Wilczynski, Z, Adair, JH & Matters, GL 2021, 'Aptamer-targeted calcium phosphosilicate nanoparticles for effective imaging of pancreatic and prostate cancer', International Journal of Nanomedicine, vol. 16, pp. 2297-2309. https://doi.org/10.2147/IJN.S295740
Bussard, KM, Gigliotti, CM, Adair, BM, Snyder, JM, Gigliotti, NT, Loc, WS, Wilczynski, ZR, Liu, ZK, Meisel, K, Zemanek, C, Mastro, AM, Shupp, AB, McGovern, C, Matters, GL & Adair, JH 2021, 'Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 34, 102383. https://doi.org/10.1016/j.nano.2021.102383